Intervention not reported
Milnacipran high dose RCTs: 7 Participants: 2837 · people with chronic pain Interventions: amitriptyline standard dose (25‐75 mg); desvenlafaxine high dose (> 50 mg); duloxetine low dose (<…
1 finding from 1 review
no estimate extracted
7 participants
Very low
Intervention not reported
Amitriptyline standard dose RCTs: 10 Participants: 997 · people with chronic pain Interventions: amitriptyline standard dose (25‐75 mg); desvenlafaxine high dose (> 50 mg); duloxetine low dose (<…
1 finding from 1 review
no estimate extracted
10 participants
Very low
Intervention not reported
Duloxetine high dose RCTs: 14 Participants: 3692 · people with chronic pain Interventions: desvenlafaxine high dose (≥ 50 mg); duloxetine low dose (< 60 mg), standard dose (60 mg), and high…
1 finding from 1 review
no estimate extracted
14 participants
Moderate
Intervention not reported
Esreboxetine standard dose RCTs: 1 Participants: 783 · people with chronic pain Interventions: amitriptyline standard dose (25‐75 mg); desvenlafaxine high dose (> 50 mg); duloxetine low dose (<…
1 finding from 1 review
no estimate extracted
1 participants
Very low
Intervention not reported
Milnacipran high dose RCTs: 1 Participants: 384 · people with chronic pain Interventions: desvenlafaxine high dose (≥ 50 mg); duloxetine low dose (< 60 mg), standard dose (60 mg), and high…
1 finding from 1 review
no estimate extracted
1 participants
Very low
Intervention not reported
Esreboxetine standard dose RCTs: 1 Participants: 828 · people with chronic pain Interventions: desvenlafaxine high dose (≥ 50 mg); duloxetine low dose (< 60 mg), standard dose (60 mg), and high…
1 finding from 1 review
no estimate extracted
1 participants
Low
Intervention not reported
Milnacipran standard dose RCTs: 2 Participants: 1298 · people with chronic pain Interventions: desvenlafaxine high dose (≥ 50 mg); duloxetine low dose (< 60 mg), standard dose (60 mg), and high…
1 finding from 1 review
no estimate extracted
2 participants
Low
Intervention not reported
Mirtazapine standard dose RCTs: 1 Participants: 422 · people with chronic pain Interventions: desvenlafaxine high dose (≥ 50 mg); duloxetine low dose (< 60 mg), standard dose (60 mg), and high…
1 finding from 1 review
no estimate extracted
1 participants
Low
Intervention not reported
Esreboxetine high dose RCTs: 1 Participants: 555 · people with chronic pain Interventions: desvenlafaxine high dose (≥ 50 mg); duloxetine low dose (< 60 mg), standard dose (60 mg), and high…
1 finding from 1 review
no estimate extracted
1 participants
Very low
Food intake · cancer cachexia in adults
1 finding from 1 review
Weight (kg) · cancer cachexia in adults
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Adverse events · cancer cachexia in adults
1 finding from 1 review
Intervention not reported
Clinical success (eg 50% reduction in pain) Acute conditions · adults with strains or sprains (acute) or osteoarthritis or low back pain (chronic)
1 finding from 1 review
Intervention not reported
Clinical success (eg 50% reduction in pain) Chronic conditions · adults with strains or sprains (acute) or osteoarthritis or low back pain (chronic)
1 finding from 1 review
Intervention not reported
Adverse events ‐ any adverse events Acute and chronic conditions combined · adults with strains or sprains (acute) or osteoarthritis or low back pain (chronic)
1 finding from 1 review
Intervention not reported
Adverse events ‐ local adverse events Acute and chronic conditions combined · adults with strains or sprains (acute) or osteoarthritis or low back pain (chronic)
1 finding from 1 review
Intervention not reported
Withdrawals ‐ lack of efficacy Acute and chronic conditions combined · adults with strains or sprains (acute) or osteoarthritis or low back pain (chronic)
1 finding from 1 review
Intervention not reported
Withdrawals ‐ adverse events Acute and chronic conditions combined · adults with strains or sprains (acute) or osteoarthritis or low back pain (chronic)
1 finding from 1 review
Intervention not reported
At least 50% reduction in pain or equivalent · adults with complex regional pain syndrome type 1 (lower limb)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
At least 30% reduction in pain · adults with complex regional pain syndrome type 1 (lower limb)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found